Tvardi Therapeutics (TVRD) Tax Provisions: 2012-2016
Historic Tax Provisions for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to -$468,000.
- Tvardi Therapeutics' Tax Provisions fell 163.64% to -$145,000 in Q3 2017 from the same period last year, while for Sep 2017 it was -$367,000, marking a year-over-year increase of 13.85%. This contributed to the annual value of -$468,000 for FY2016, which is 17.88% down from last year.
- As of FY2016, Tvardi Therapeutics' Tax Provisions stood at -$468,000, which was down 17.88% from -$397,000 recorded in FY2015.
- Tvardi Therapeutics' Tax Provisions' 5-year high stood at -$30,000 during FY2013, with a 5-year trough of -$468,000 in FY2016.
- Moreover, its 3-year median value for Tax Provisions was -$397,000 (2015), whereas its average is -$355,333.
- As far as peak fluctuations go, Tvardi Therapeutics' Tax Provisions grew by 3.23% in 2013, and later crashed by 570.00% in 2014.
- Tvardi Therapeutics' Tax Provisions (Yearly) stood at -$31,000 in 2012, then rose by 3.23% to -$30,000 in 2013, then tumbled by 570.00% to -$201,000 in 2014, then slumped by 97.51% to -$397,000 in 2015, then declined by 17.88% to -$468,000 in 2016.